Product
C-peptide proinsulin ratio
1 clinical trial
4 indications
Indication
HypoglycemiaIndication
NeonatalIndication
PretermIndication
Glibenclamide adverse reactionClinical trial
Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)Status: Recruiting, Estimated PCD: 2026-02-01